Rediscovering secondary tumors of the prostate in the molecular era

Nicola Fusco, Amedeo Sciarra, Elena Guerini Rocco, Caterina Marchiò, Francesca Vignani, Piergiuseppe Colombo, Stefano Ferrero

Research output: Contribution to journalArticle

Abstract

Metastatic involvement of the prostate from noncontiguous solid tumors is a rare event occurring by means of vascular dissemination. The reported cases of biopsy and surgical samples with metastatic involvement have increased; however, a comprehensive understanding of secondary tumors of the prostate is currently missing. Metastases to the prostate carry a dismal prognosis and may pose serious diagnostic challenges to both clinicians and pathologists, with crucial therapeutic implications. Secondary tumors of the prostate spread more frequently from the digestive tract, the lung, and the kidney. The integration of clinicoradiologic data with appropriate pathologic and immunohistochemical analyses is essential for the identification and the characterization of secondary tumors of the prostate, whereas molecular analyses could provide additional and complementary information, enabling precise diagnosis and appropriate clinical management. Patients with solitary metastases could benefit from prostatic resection and adjuvant therapy, whereas in cases of disseminated diseases, symptom control may be obtained with palliative procedures. The purpose of this review was to assess the current state of knowledge of secondary tumors involving the prostate gland and to discuss short-term future perspectives, while providing a practical approach to these uncommon conditions for pathologists and oncologists.

Original languageEnglish
Pages (from-to)170-179
Number of pages10
JournalAdvances in Anatomic Pathology
Volume23
Issue number3
DOIs
Publication statusPublished - 2016

Fingerprint

Prostate
Neoplasms
Neoplasm Metastasis
Blood Vessels
Gastrointestinal Tract
Kidney
Biopsy
Lung
Therapeutics
Pathologists

Keywords

  • Immunohistochemistry
  • Metastasis
  • Molecular studies
  • Prostate
  • Review
  • Secondary tumor

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Anatomy

Cite this

Rediscovering secondary tumors of the prostate in the molecular era. / Fusco, Nicola; Sciarra, Amedeo; Guerini Rocco, Elena; Marchiò, Caterina; Vignani, Francesca; Colombo, Piergiuseppe; Ferrero, Stefano.

In: Advances in Anatomic Pathology, Vol. 23, No. 3, 2016, p. 170-179.

Research output: Contribution to journalArticle

@article{b9eedad8c11744bbadc0aa67cea8b271,
title = "Rediscovering secondary tumors of the prostate in the molecular era",
abstract = "Metastatic involvement of the prostate from noncontiguous solid tumors is a rare event occurring by means of vascular dissemination. The reported cases of biopsy and surgical samples with metastatic involvement have increased; however, a comprehensive understanding of secondary tumors of the prostate is currently missing. Metastases to the prostate carry a dismal prognosis and may pose serious diagnostic challenges to both clinicians and pathologists, with crucial therapeutic implications. Secondary tumors of the prostate spread more frequently from the digestive tract, the lung, and the kidney. The integration of clinicoradiologic data with appropriate pathologic and immunohistochemical analyses is essential for the identification and the characterization of secondary tumors of the prostate, whereas molecular analyses could provide additional and complementary information, enabling precise diagnosis and appropriate clinical management. Patients with solitary metastases could benefit from prostatic resection and adjuvant therapy, whereas in cases of disseminated diseases, symptom control may be obtained with palliative procedures. The purpose of this review was to assess the current state of knowledge of secondary tumors involving the prostate gland and to discuss short-term future perspectives, while providing a practical approach to these uncommon conditions for pathologists and oncologists.",
keywords = "Immunohistochemistry, Metastasis, Molecular studies, Prostate, Review, Secondary tumor",
author = "Nicola Fusco and Amedeo Sciarra and {Guerini Rocco}, Elena and Caterina Marchi{\`o} and Francesca Vignani and Piergiuseppe Colombo and Stefano Ferrero",
year = "2016",
doi = "10.1097/PAP.0000000000000115",
language = "English",
volume = "23",
pages = "170--179",
journal = "Advances in Anatomic Pathology",
issn = "1072-4109",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Rediscovering secondary tumors of the prostate in the molecular era

AU - Fusco, Nicola

AU - Sciarra, Amedeo

AU - Guerini Rocco, Elena

AU - Marchiò, Caterina

AU - Vignani, Francesca

AU - Colombo, Piergiuseppe

AU - Ferrero, Stefano

PY - 2016

Y1 - 2016

N2 - Metastatic involvement of the prostate from noncontiguous solid tumors is a rare event occurring by means of vascular dissemination. The reported cases of biopsy and surgical samples with metastatic involvement have increased; however, a comprehensive understanding of secondary tumors of the prostate is currently missing. Metastases to the prostate carry a dismal prognosis and may pose serious diagnostic challenges to both clinicians and pathologists, with crucial therapeutic implications. Secondary tumors of the prostate spread more frequently from the digestive tract, the lung, and the kidney. The integration of clinicoradiologic data with appropriate pathologic and immunohistochemical analyses is essential for the identification and the characterization of secondary tumors of the prostate, whereas molecular analyses could provide additional and complementary information, enabling precise diagnosis and appropriate clinical management. Patients with solitary metastases could benefit from prostatic resection and adjuvant therapy, whereas in cases of disseminated diseases, symptom control may be obtained with palliative procedures. The purpose of this review was to assess the current state of knowledge of secondary tumors involving the prostate gland and to discuss short-term future perspectives, while providing a practical approach to these uncommon conditions for pathologists and oncologists.

AB - Metastatic involvement of the prostate from noncontiguous solid tumors is a rare event occurring by means of vascular dissemination. The reported cases of biopsy and surgical samples with metastatic involvement have increased; however, a comprehensive understanding of secondary tumors of the prostate is currently missing. Metastases to the prostate carry a dismal prognosis and may pose serious diagnostic challenges to both clinicians and pathologists, with crucial therapeutic implications. Secondary tumors of the prostate spread more frequently from the digestive tract, the lung, and the kidney. The integration of clinicoradiologic data with appropriate pathologic and immunohistochemical analyses is essential for the identification and the characterization of secondary tumors of the prostate, whereas molecular analyses could provide additional and complementary information, enabling precise diagnosis and appropriate clinical management. Patients with solitary metastases could benefit from prostatic resection and adjuvant therapy, whereas in cases of disseminated diseases, symptom control may be obtained with palliative procedures. The purpose of this review was to assess the current state of knowledge of secondary tumors involving the prostate gland and to discuss short-term future perspectives, while providing a practical approach to these uncommon conditions for pathologists and oncologists.

KW - Immunohistochemistry

KW - Metastasis

KW - Molecular studies

KW - Prostate

KW - Review

KW - Secondary tumor

UR - http://www.scopus.com/inward/record.url?scp=84964501711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964501711&partnerID=8YFLogxK

U2 - 10.1097/PAP.0000000000000115

DO - 10.1097/PAP.0000000000000115

M3 - Article

VL - 23

SP - 170

EP - 179

JO - Advances in Anatomic Pathology

JF - Advances in Anatomic Pathology

SN - 1072-4109

IS - 3

ER -